Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Emerging Microbes & Infections|August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical diseaseDeclan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine|December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primatesRuth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Journal of Virology|June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaquesGabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Emerging Microbes & Infections|August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical diseaseDeclan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine|December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primatesRuth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Journal of Virology|June 10, 2025
Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaquesGabriella Worwa, Carl W Davis, Sarah E Klim, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Pageof 13